Preemptive Local Anesthesia in Vaginal Surgery

Preemptive analgesia is an intervention which provides an anesthetic prior to initiating a painful stimulus. This trial is examining the effects of a local anesthetic given at the point of innervation prior to performing a vaginal hysterectomy with suspension sutures.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain, Postoperative Neurologic Manifestations Pain Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Mayo Clinic

Scottsdale, Arizona, 85259, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women undergoing vaginal hysterectomy with McCall's culdoplasty

Treatment and study plan

bupivacaine and epinephrine

Drug

20 ml of 0.5% bupivacaine with 1:200,000 epinephrine paracervical injection.

Placebo

Drug

20 ml normal saline injection.

Primary outcomes

Visual Analogue Scale (VAS) Pain Score

Time frame: 30 minutes post-op

Visual Analogue Scale (VAS) pain score on a scale from 0 (None) to 10 (Worst) points.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Preemptive Local Anesthesia in Vaginal Surgery, A Prospective, Randomised Trial

Important dates

Study start: 2006
Primary completion: 2008
Study completion: 2008
First posted: Apr 26, 2006
Registry last updated: Nov 18, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed